VTRS FY 2016 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11.1B+17.5% YoY

Gross Profit

$4.7B42.4% margin

Operating Income

$699M6.3% margin

Net Income

$480M4.3% margin

EPS (Diluted)

$0.92

Cash Flow

Operating Cash Flow

$2.0B

Free Cash Flow

$1.7B

Stock-Based Comp.

$89M

Balance Sheet

Total Assets

$34.7B

Total Liabilities

$23.6B

Stockholders' Equity

$11.1B

Cash & Equivalents

$999M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.1B	$9.4B	+17.5%
Gross Profit	$4.7B	$4.2B	+11.4%
Operating Income	$699M	$1.5B	-52.1%
Net Income	$480M	$848M	-43.4%